CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 Genetic Polymorphisms in Chronic Myeloid Leukemia: A Case-Control Study

المؤلفون المشاركون

Bănescu, Claudia
Dima, Delia
Voidăzan, Septimiu
Moldovan, Valeriu G.
Macarie, Ioan
Dobreanu, Minodora
Benedek Lazar, Erzsebeth
Trifa, Adrian P.
Duicu, Carmen

المصدر

Oxidative Medicine and Cellular Longevity

العدد

المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-6، 6ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2014-11-10

دولة النشر

مصر

عدد الصفحات

6

التخصصات الرئيسية

الأحياء

الملخص EN

Oxidative damage at the DNA level may be promoted by high levels of reactive oxygen species (ROS), leading to genomic instability and increased neoplastic risk.

Superoxide dismutase (SOD), glutathione peroxidase (GPX), and catalase (CAT) enzymes are implicated in the prevention of DNA damage by ROS.

The aim of the study was to investigate the relationships between CAT C262T, GPX1 Pro198Leu, MnSOD Ala16Val, GSTM1, GSTT1, and GSTP1 Ile105Val polymorphisms and the risk of CML.

No association was observed between CML and variant genotypes of GPX1, MnSOD, GSTM1, and GSTT1 polymorphisms in any of the investigated cases.

Our study suggests that the homozygous variant genotype of the GSTP1 Ile105Val gene polymorphisms may be associated with the risk of developing CML ( OR = 2.5 ; 95% CI = 1.08 –5.7; P value = 0.02), while the heterozygous genotype of the CAT C262T polymorphism seems to have a protective effect against CML ( OR = 0.59 , 95% CI = 0.39 –0.89, P value = 0.01).

In most cases, no association was found between laboratory parameters and prognostic factors and the variant genotype of investigated gene polymorphisms.

We concluded that CAT, GPX, MnSOD, GSTM1, and GSTT1 gene polymorphisms are not associated with the risk of CML.

Variant genotype of the GSTP1 Ile105Val gene polymorphisms may contribute to the risk of developing CML.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Bănescu, Claudia& Trifa, Adrian P.& Voidăzan, Septimiu& Moldovan, Valeriu G.& Macarie, Ioan& Benedek Lazar, Erzsebeth…[et al.]. 2014. CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 Genetic Polymorphisms in Chronic Myeloid Leukemia: A Case-Control Study. Oxidative Medicine and Cellular Longevity،Vol. 2014, no. 2014, pp.1-6.
https://search.emarefa.net/detail/BIM-1047153

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Bănescu, Claudia…[et al.]. CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 Genetic Polymorphisms in Chronic Myeloid Leukemia: A Case-Control Study. Oxidative Medicine and Cellular Longevity No. 2014 (Dec. 2014), pp.1-6.
https://search.emarefa.net/detail/BIM-1047153

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Bănescu, Claudia& Trifa, Adrian P.& Voidăzan, Septimiu& Moldovan, Valeriu G.& Macarie, Ioan& Benedek Lazar, Erzsebeth…[et al.]. CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 Genetic Polymorphisms in Chronic Myeloid Leukemia: A Case-Control Study. Oxidative Medicine and Cellular Longevity. 2014. Vol. 2014, no. 2014, pp.1-6.
https://search.emarefa.net/detail/BIM-1047153

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1047153